VIRIDIAN THERAPEUTICS, INC.
Income flow
Annual
VRDN 10-K Income StatementPeriod 2025-12-31Source 10-K
As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.
Revenue mix
2025-12-31 · 10-K · USD
By activity
- License$70M98.8%
- Collaboration$849,0001.2%
Capital & dividends
YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0Shares outTotal shares currently outstanding (issued and not retired).113.3MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).100.8M
Dividend calendar
- Pay date
- 2020-11-13
Shares outstanding (as-filed)
67.9M24
84.8M25
Stock splits
- 1:152020-11-13
- 1:152016-11-07